Triptorelin (Precocious Puberty)

Precocious puberty is a condition in which puberty starts earlier than expected. This page provides information on the use and management of triptorelin treatment to help delay the progression of puberty where clinically appropriate.

The prescribing guidance, formularies, pathways and information on this website have transferred from the predecessor organisations that now form NHS Central East ICB.

Guidance may not be available for all clinical topics or geographic areas. Where guidance is available, it is clearly identified as applying to Bedfordshire, Luton and Milton Keynes (BLMK), Cambridgeshire and Peterborough (C&P), Hertfordshire or Central East (CE).

Guidance labelled Central East (CE) has been harmonised and approved for use across NHS Central East ICB. Where CE guidance is not available, local arrangements for BLMK, C&P or Hertfordshire remain in place.

For Hertfordshire prescribing guidance, please visit: www.hweclinicalguidance.nhs.uk

Cambridgeshire and Peterborough

Triptorelin 4 weekly administration/ 12 weekly administration – Precocious Puberty – Shared Care Guidance (pdf)